{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/59676-280#drug","name":"EDURANT PED","alternateName":"rilpivirine hydrochloride","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"59676-280"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"NDA219016"},{"@type":"PropertyValue","propertyID":"UNII","value":"212WAX8KDD"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"03880372-2c68-45c6-a53a-f420c49541d6"}],"activeIngredient":"RILPIVIRINE HYDROCHLORIDE","administrationRoute":["ORAL"],"dosageForm":"TABLET, FOR SUSPENSION","manufacturer":{"@type":"Organization","name":"Janssen Products, LP"},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/NDA219016","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=03880372-2c68-45c6-a53a-f420c49541d6","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=59676-280"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-01T21:59:23.044Z"}}